Fei Peng

Fei Peng


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WCWei Chen
Wei Chen
LLLimin Liu
Limin Liu
HZHeng Zhao
Heng Zhao
HLHui Li
Hui Li
JLJing Luo
Jing Luo
FPFei Peng
Fei Peng
To determine the diagnostic performance of dual-energy CT (DECT) virtual noncalcium (VNCa) technique in the detection of bone marrow lesions (BMLs) in knee osteoarthritis, and further analyze the correlation between the severity of BMLs on VNCa image and the degree of knee pain. 23 consecutive patients with clinically diagnosed knee osteoarthritis were underwent DECT and 3.0T MRI between August 2017 and November 2018. Evaluation of two pain assessment scales (WOMAC and KOOS) were collected. VNCa images and MRI were independently scored by three readers using a four-level scoring system over 15 anatomical subregions in each knee joint. Spearman correlation coefficient was used for total BML scores on DECT and MRI correlation with WOMAC and KOOS. Specificity, Sensitivity, NPV and PPV of reader 1 and reader 2 were 99.4%/99.2%, 89.4%/87.2%, 98.6%/98.3% and 95.5%/93.2%. A cutoff value of − 41.5 HU/− 46.5 HU provided sensitivities of 93.2%/90.9% and specificities of 100.0%/93.9% for diagnosing BMLs with AUC of 0.970/0.996. A stronger correlation was observed between the WOMAC and total BML score compared to the KOOS. DECT possessed excellent diagnostic performance in the detection of BMLs in knee osteoarthritis. And the pain degree increased with the severity of BMLs on VNCa images.

14 December 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
FPFei Peng
Fei Peng
DTDeqiu Tang
Deqiu Tang
WQWeipeng Qing
Weipeng Qing
WCWei Chen
Wei Chen
SLShuhao Li
Shuhao Li
HZHeng Zhao
Heng Zhao

4 March 2025 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
FPFei Peng
Fei Peng
HXHuayan Xu
Huayan Xu
TXTing Xu
Ting Xu
KXKe Xu
Ke Xu
XCXiaotang Cai
Xiaotang Cai
LLLimin Liu
Limin Liu

24 February 2026 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
WGWenbin Gu
Wenbin Gu
YLYusheng Li
Yusheng Li
FWFang Wang
Fang Wang
CWChunyu Wu
Chunyu Wu
ZPZhaojie Peng
Zhaojie Peng
FPFei Peng
Fei Peng
Background: Chest computed tomography (CT) seldom covers the third lumbar (L3) vertebral level, the standard landmark for assessing total body muscle mass. As muscle measurements at the fourth thoracic (T4) level show high concordance with those at L3, the T4 level may serve as a viable alternative. We evaluated the discriminatory performance of T4 musculature for lung cancer–related low thoracic muscle mass (LTMM) and its association with Eastern Cooperative Oncology Group (ECOG) performance status. Methods: We retrospectively included 289 inpatients with newly diagnosed lung cancer who underwent chest CT within 3 months. At T4, the pectoralis major, pectoralis minor, and chest–wall muscle group were segmented to derive cross–sectional area (CSA), density, and height–normalized indices (cm 2 /m 2 ). Low thoracic muscle mass (LTMM) was defined by sex–specific 25th–percentile thoracic 4th vertebra level muscle index (T4MI) cutoffs (40.78 cm 2 /m 2 for men, 33.15 cm 2 /m 2 for women). Patients were stratified by sex and clinical stage (I–II early–stage vs. III–IV advanced–stage). ROC analyses compared discriminatory performance; logistic regression tested associations with poor ECOG performance status. Results: Compared with non–low thoracic muscle mass (non–LTMM), low thoracic muscle mass (LTMM) group showed smaller CSA, lower density, and reduced indices. Across muscle groups, indices outperformed CSA and density. The pectoralis major index achieved the highest AUC in the overall cohort (AUC = 0.833) and reached excellent discrimination in the overall male cohort (AUC = 0.922). Notably, stage–stratified analyses showed consistently superior discriminatory performance for the pectoralis major index in the male population (early–stage AUC = 0.917, advanced–stage AUC = 0.912). In addition, the pectoralis major index was independently associated with poor ECOG performance status (odds ratio = 0.932, p = 0.009). Conclusion: T4-level muscle metrics showed good internal discrimination for lung cancer–related low thoracic muscle mass across sex and disease stage, with the pectoralis major index achieving the highest overall performance. Moreover, the pectoralis major index may be a potential imaging biomarker associated with ECOG performance status.


26 March 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
XCXiaolong Chen
Xiaolong Chen
MTMeidi Tan
Meidi Tan
LLLimin Liu
Limin Liu
LYLu Ye
Lu Ye
CWChunyu Wu
Chunyu Wu
FPFei Peng
Fei Peng
Objective: To describe the correlation between abdominal muscle mass and CAC in T2DM patients using DSCT, and to determine the preferred muscle imaging indicators in diagnosing and predicting positive CAC patients. Materials and methods: 108 T2DM patients were included (57.0 ± 10.9 years old). We acquired both CAC score and abdominal-chest DSCT data. DSCT measurements (intermuscular adipose tissue [IMAT], total abdominal muscle area [TAMA], normal attenuation muscle area [NAMA], low attenuation muscle area [LAMA], fat fraction [FF], LAMA/body mass index [BMI], NAMA/BMI, and NAMA/TAMA index) of 7 muscles (psoas major [PM], quadratus lumborum [QL], erector spinae [ES], rectus abdominis [RA], transversus abdominis [TA], oblique abdominals [OA], abdominal core muscles [ACM]) on the level of the third lumbar vertebra were conducted. T2DM patients were divided into four subgroups based on CAC score: negative controls (NCs) (0 score), mild (300 score). The following statistical analyses were conducted: intergroup differences were compared using the Mann-Whitney test, diagnostic performance was evaluated via receiver operating characteristic (ROC) curve analysis, associations were assessed with Spearman correlation, and predictors were identified through logistic regression. A P -value <0.05 was considered statistically significant. Result: Compared with NCs, TAMA, NAMA, NAMA/BMI, and NAMA/TAMA index were significantly higher in the group of all CAC ( P <0.05), while TAMA was significantly lower ( P <0.05). The NAMA, NAMA/BMI and the NAMA/TAMA index in four representative muscles (PM, QL, ES, and RA) demonstrated certain diagnostic performance (AUC range, 0.70-0.97, 0.85-0.99 and 0.81-0.97). Overall, NAMA/TAMA index in OA exhibited the strongest negative correlation with CAC score (r=-0.56, P < 0.01), and NAMA/BMI in the ACM emerged as an independent risk factor for positive CAC (odds ratio=0.63, P = 0.02). Conclusion: Abdominal muscle mass measured by DSCT was significantly associated with CAC score in T2DM patients. Overall, the NAMA/BMI showed optimal diagnostic value for CAC across severity levels. Moreover, NAMA/BMI in the ACM may serve as a predictive biomarker for positive CAC.